Wuhan Keqian Biology Co.,Ltd
SSE:688526.SS
17 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 245.189 | 276.417 | 264.996 | 194.258 | 204.929 | 238.386 | 295.6 | 252.325 | 279.515 | 314.748 | 292.894 | 190.966 | 202.66 | 327.29 | 230.684 | 226.119 | 318.927 | 238.948 | 249.169 | 180.179 | 174.933 | 118.581 | 102.222 | 130.532 | 143.354 |
| Cost of Revenue
| 83.668 | 101.85 | 92.302 | 83.248 | 68.368 | 79.99 | 76.443 | 77.171 | 63.343 | 78.185 | 78.533 | 52.687 | 54.82 | 61.006 | 61.973 | 47.856 | 51.923 | 44.65 | 37.647 | 28.445 | 34.449 | 33.642 | 20.873 | 22.838 | 26.572 |
| Gross Profit
| 161.521 | 174.567 | 172.694 | 111.011 | 136.561 | 158.396 | 219.157 | 175.154 | 216.172 | 236.563 | 214.361 | 138.279 | 147.84 | 266.284 | 168.712 | 178.264 | 267.005 | 194.298 | 211.522 | 151.733 | 140.484 | 84.94 | 81.349 | 107.695 | 116.782 |
| Gross Profit Ratio
| 0.659 | 0.632 | 0.652 | 0.571 | 0.666 | 0.664 | 0.741 | 0.694 | 0.773 | 0.752 | 0.732 | 0.724 | 0.729 | 0.814 | 0.731 | 0.788 | 0.837 | 0.813 | 0.849 | 0.842 | 0.803 | 0.716 | 0.796 | 0.825 | 0.815 |
| Reseach & Development Expenses
| 21.331 | 0 | 20.793 | 18.239 | 19.841 | 24.005 | 20.69 | 22.307 | 21.503 | 35.798 | 20.721 | 22.294 | 23.936 | 23.205 | 18.534 | 17.225 | 21.039 | 18.264 | 15.619 | 13.506 | 11.69 | 11.42 | 8.339 | 15.589 | 13.803 |
| General & Administrative Expenses
| 14.372 | 0 | 36.77 | -5.552 | 11.186 | -31.004 | 40.252 | -5.1 | 13.682 | -40.844 | 44.388 | -1.206 | 12.617 | -32.544 | 41.04 | -7.699 | 26.9 | -13.37 | 11.741 | -2.152 | 5.395 | -18.018 | 11.307 | 7.435 | 7.62 |
| Selling & Marketing Expenses
| 27.319 | 0 | 64.5 | 24.259 | 31.849 | 33.957 | 47.573 | 31.708 | 41.599 | 59.428 | 44.715 | 32.502 | 23.24 | 34.385 | 36.654 | 30.028 | 32.858 | 29.824 | 36.334 | 28.461 | 18.223 | 29.339 | 19.004 | 21.237 | 17.992 |
| SG&A
| 41.691 | -63.115 | 101.27 | 39.362 | 43.035 | 2.954 | 87.825 | 26.608 | 55.28 | 18.584 | 89.103 | 31.295 | 35.856 | 1.841 | 77.693 | 22.33 | 59.757 | 16.454 | 48.075 | 26.309 | 23.618 | 11.321 | 30.311 | 28.147 | 25.827 |
| Other Expenses
| -27.175 | 71.374 | -73.281 | -6.794 | -0.615 | -573.038 | 0.595 | 0.005 | -1.775 | 43.347 | -28.656 | 21.131 | -2.425 | 0.727 | -0.179 | -1.498 | -0.003 | -3.064 | 0.004 | -0.578 | -0.995 | -0.721 | -0.005 | 0 | 0 |
| Operating Expenses
| 35.847 | 33.227 | 48.782 | 64.394 | 52.266 | 573.038 | 76.759 | 71.958 | 75.009 | 97.728 | 81.168 | 74.72 | 57.367 | 69.142 | 69.415 | 60.546 | 81.414 | 56.824 | 60.547 | 47.199 | 35.447 | 39.628 | 38.46 | 34.607 | 34.666 |
| Operating Income
| 125.674 | 129.942 | 123.912 | 46.616 | 100.625 | -334.652 | 136.054 | 118.802 | 157.887 | 143.918 | 143.679 | 76.354 | 102.763 | 214.763 | 114.239 | 137.549 | 194.452 | 151.652 | 158.733 | 105.419 | 108.506 | 55.364 | 45.772 | 73.63 | 76.392 |
| Operating Income Ratio
| 0.513 | 0.47 | 0.468 | 0.24 | 0.491 | -1.404 | 0.46 | 0.471 | 0.565 | 0.457 | 0.491 | 0.4 | 0.507 | 0.656 | 0.495 | 0.608 | 0.61 | 0.635 | 0.637 | 0.585 | 0.62 | 0.467 | 0.448 | 0.564 | 0.533 |
| Total Other Income Expenses Net
| -0.179 | 0.502 | -0.03 | -0.051 | -0.615 | -0.462 | 0.595 | 0.005 | -1.688 | -0.11 | -0.063 | 0.053 | 0.013 | 0.727 | -0.179 | -1.498 | -0.003 | -3.064 | 0.004 | -0.594 | -0.995 | -0.767 | -0.005 | 0.019 | 0.009 |
| Income Before Tax
| 125.495 | 130.443 | 123.882 | 72.92 | 100.01 | 70.121 | 136.649 | 118.807 | 156.199 | 143.808 | 143.616 | 76.407 | 102.777 | 215.49 | 114.06 | 136.051 | 194.448 | 148.588 | 158.737 | 104.826 | 107.511 | 54.596 | 45.767 | 83.953 | 88.969 |
| Income Before Tax Ratio
| 0.512 | 0.472 | 0.467 | 0.375 | 0.488 | 0.294 | 0.462 | 0.471 | 0.559 | 0.457 | 0.49 | 0.4 | 0.507 | 0.658 | 0.494 | 0.602 | 0.61 | 0.622 | 0.637 | 0.582 | 0.615 | 0.46 | 0.448 | 0.643 | 0.621 |
| Income Tax Expense
| 17.709 | 15.376 | 16.111 | 7.76 | 12.934 | 7.526 | 18.446 | 15.262 | 20.767 | 17.904 | 19.433 | 8.108 | 12.017 | 30.76 | 14.296 | 18.859 | 25.498 | 20.524 | 21.894 | 14.522 | 14.919 | 2.863 | 9.67 | 9.02 | 11.562 |
| Net Income
| 108.237 | 115.068 | 107.992 | 65.38 | 87.228 | 61.223 | 118.262 | 103.629 | 135.537 | 126.089 | 124.316 | 68.347 | 90.766 | 184.834 | 99.765 | 117.192 | 168.951 | 128.063 | 136.843 | 90.304 | 92.593 | 51.733 | 36.096 | 74.933 | 77.407 |
| Net Income Ratio
| 0.441 | 0.416 | 0.408 | 0.337 | 0.426 | 0.257 | 0.4 | 0.411 | 0.485 | 0.401 | 0.424 | 0.358 | 0.448 | 0.565 | 0.432 | 0.518 | 0.53 | 0.536 | 0.549 | 0.501 | 0.529 | 0.436 | 0.353 | 0.574 | 0.54 |
| EPS
| 0.23 | 0.24 | 0.23 | 0.14 | 0.18 | 0.13 | 0.25 | 0.22 | 0.29 | 0.27 | 0.27 | 0.15 | 0.2 | 0.4 | 0.21 | 0.25 | 0.36 | 0.34 | 0.36 | 0.25 | 0.26 | 0.14 | 0.1 | 0.21 | 0.215 |
| EPS Diluted
| 0.23 | 0.24 | 0.23 | 0.14 | 0.18 | 0.13 | 0.25 | 0.22 | 0.29 | 0.27 | 0.27 | 0.15 | 0.2 | 0.4 | 0.21 | 0.25 | 0.36 | 0.34 | 0.36 | 0.25 | 0.26 | 0.14 | 0.1 | 0.21 | 0.215 |
| EBITDA
| 125.57 | 129.942 | 125.089 | 101.347 | 129.1 | 75.597 | 167.064 | 150.044 | 187.53 | 173.526 | 143.839 | 100.201 | 124.073 | 234.028 | 132.273 | 149.764 | 208.439 | 148.633 | 159.045 | 104.899 | 111.952 | 54.596 | 51.394 | 82.857 | 85.619 |
| EBITDA Ratio
| 0.512 | 0.47 | 0.472 | 0.522 | 0.63 | 0.317 | 0.565 | 0.595 | 0.671 | 0.551 | 0.491 | 0.525 | 0.612 | 0.715 | 0.573 | 0.662 | 0.654 | 0.622 | 0.638 | 0.582 | 0.64 | 0.46 | 0.503 | 0.635 | 0.597 |